GHK-Cu (copper tripeptide-1) is one of the most studied peptides in skin and connective-tissue research. This research overview explains what GHK-Cu is, the pathways researchers investigate, and how it is handled in the lab - strictly for research purposes.

What Is GHK-Cu?

GHK-Cu is a naturally occurring copper-binding tripeptide widely studied in regenerative research. It is supplied as a lyophilised powder and reconstituted with bacteriostatic water before laboratory use. GHK-Cu is examined in controlled research models.

GHK-Cu and Tissue-Remodelling Research

Much of the interest in GHK-Cu concerns its studied role in tissue-remodelling and copper-transport signalling within research models. These remain active areas of laboratory investigation.

GHK-Cu in the Lab

GHK-Cu is offered as a research-grade compound in the MYOLABS Research Series and is frequently studied alongside recovery research peptides such as the GLOW (BPC-157 + GHK-Cu + TB-500) blend.

How GHK-Cu Is Handled

Store the lyophilised powder cool and dark; reconstitute only before use and refrigerate afterward. MYOLABS GHK-Cu is third-party tested with a Certificate of Analysis available.

Frequently Asked Questions

What is GHK-Cu studied for?
In research, GHK-Cu is studied for its role in tissue-remodelling and copper-transport signalling. It is a research compound only.

Is GHK-Cu the same as copper peptides generally?
GHK-Cu is a specific copper tripeptide; 'copper peptides' is a broader category. GHK-Cu is the most-studied of them.

Does MYOLABS provide a COA for GHK-Cu?
Yes - third-party tested with a Certificate of Analysis available on request.

Research Use Only

All information here is provided for educational and laboratory-research purposes only. GHK-Cu supplied by MYOLABS is for laboratory research use only - it is not for human consumption, is not a medicine, and is not intended to diagnose, treat, cure, or prevent any disease. Researchers must comply with all applicable local laws and institutional guidelines.